CHR. HANSEN A/S
Company Snapshot
Founded: 1874
Entity Type: Public
Employees: 3834
Region: Europe Middle East and Africa (EMEA)
Revenue: $1,339.8 Millions
Revenue Year: 2022
Headquarter: Denmark
Key Geographics: North America, Europe, Middle East and Africa, Latin America, Asia-Pacific
Corporate Address: Boege Alle 10-12 2970 Hoersholm Denmark Tel: +45-4574-7474 Web: www.chr-hansen.com
Company Overview
Chr. Hansen A/S is an international, differentiated bioscience organization that produces natural ingredient solutions for the food, agricultural, and pharmaceutical industries. The company operates in business such as food cultures & enzymes and health & nutrition. It has developed a broad range of product solutions based on R&D in microbial and fermentation technology for food cultures & enzymes, plant health, animal health, human health and probiotics. The company operates in 30 countries.
In January 2024, Chr. Hansen merged with Novozymes A/S, the Denmark-based supplier of enzymes and cultures. The merged company is now known as Novonesis.
Financial Highlights (FY 2022)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
CHR. HANSEN A/S In News
Company's Business Segments
- Food Cultures & Enzymes : This segment offers enzymes and probiotic products that helps in determining the taste, texture, flavor, nutritional value, shelf life, and health benefits across numerious consumer products in the food and dairy industry.
- Health & Nutrition : This segment provides products for the dietary supplement, animal feed, infant formula, over-the-counter pharmaceutical, and plant protection industries.
Applications/End User Industries
- Food Industry
- Pharmaceutical Industry
- Nutritional Industry
- Agriculture Industry
BCC Research Beacon 